Research Topics
| Maria R CostanzoSummaryAffiliation: Midwest Heart Specialists Country: USA Publications
| Collaborators
|
Detail Information
Publications
Prospective evaluation of elastic restraint to lessen the effects of heart failure (PEERLESS-HF) trialMaria Rosa Costanzo
Midwest Heart Foundation, Edward Heart Hospital, 4th Floor, 801 South Washington Street, P O Box 3226, Naperville, IL 60566, USA
J Card Fail 18:446-58. 2012..To evaluate the safety and efficacy of the HeartNet Ventricular Support System in HF patients receiving optimal medical therapy...- Isolated ultrafiltration in heart failure patientsMaria Rosa Costanzo
Midwest Heart Foundation, Edward Heart Hospital, 801 South Washington Street, Naperville, IL 60189, USA
Curr Cardiol Rep 14:254-64. 2012..Unanswered questions regarding ultrafiltration in heart failure patients include optimal fluid removal rates, effect on long-term survival, and cost... - Extracorporeal ultrafiltration in heart failure and cardio-renal syndromesMaria Rosa Costanzo
Midwest Heart Foundation, Lombard, IL, USA
Semin Nephrol 32:100-11. 2012..These new technologies may help to cope with the increasing demand for care of chronic heart failure patients... - Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosisMaria Rosa Costanzo
Midwest Heart Foundation, Edward Heart Hospital, 4th Floor, 801 South Washington Street, P O Box 3226, Naperville, IL 60566, USA
Heart Fail Rev 17:313-24. 2012..037) in a randomized controlled trial of patients with decompensated heart failure. Future larger controlled clinical trials should evaluate further the effect of ultrafiltration on patients' outcomes, including survival... 
The role of ultrafiltration in the management of heart failureMaria Rosa Costanzo
Midwest Heart Foundation, Edward Heart Hospital, Naperville, IL 60566, USA
Congest Heart Fail 14:19-24. 2008..Recent clinical trial data suggest that ultrafiltration may also reduce rehospitalizations for worsening heart failure...- The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Maria Rosa Costanzo
Midwest Heart Foundation, Lombard, IL, USA
Am Heart J 154:267-77. 2007..Significant concerns have been expressed regarding risks and benefits of individual therapies, especially nesiritide (NES), but few studies have compared the relative safety of varied intravenous therapies on clinical outcomes... - Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failureMaria Rosa Costanzo
Midwest Heart Foundation, Edward Heart Hospital, Lombard, Illinois 60566, USA
J Am Coll Cardiol 49:675-83. 2007..This study was designed to compare the safety and efficacy of veno-venous ultrafiltration and standard intravenous diuretic therapy for hypervolemic heart failure (HF) patients... - Ultrafiltration in the management of heart failureMaria Rosa Costanzo
Midwest Heart Foundation, Edward Heart Hospital, Naperville, Illinois 60566, USA
Curr Opin Crit Care 14:524-30. 2008..Ultrafiltration, an alternative method of sodium and water removal, safely improves hemodynamics in heart failure patients... - Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOADMaria Rosa Costanzo
Midwest Heart Foundation, Edward Heart Hospital, 801 South Washington Street, PO Box 3226, Naperville, IL 60566, USA
J Card Fail 16:277-84. 2010..Outcomes may be due to greater fluid removal, but UF removes more sodium/unit volume than diuretics... - Early ultrafiltration in patients with decompensated heart failure and diuretic resistanceMaria Rosa Costanzo
Midwest Heart Foundation, Lombard, Illinois, USA
J Am Coll Cardiol 46:2047-51. 2005..We sought to determine if ultrafiltration before intravenous (IV) diuretics in patients with decompensated heart failure and diuretic resistance results in euvolemia and early discharge without hypotension or worsening renal function... - Extracorporeal fluid removal in heart failure patientsMaria Rosa Costanzo
Midwest Heart Foundation, Naperville, Ill, USA
Contrib Nephrol 165:236-43. 2010..Ultrafiltration is the only fluid removal strategy shown to improve outcomes in randomized controlled trials of patients hospitalized with decompensated heart failure... - Extracorporeal fluid removal in heart failure patientsMaria Rosa Costanzo
Midwest Heart Foundation, Naperville, Ill, USA
Contrib Nephrol 164:173-98. 2010..Ultrafiltration is the only fluid removal strategy shown to improve outcomes in randomized controlled trials of patients hospitalized with decompensated HF... - Extracorporeal ultrafiltration for congestive heart failure patientsMaria Rosa Costanzo
Midwest Heart Foundation, Naperville, IL 60566, USA
Contrib Nephrol 171:201-7. 2011..Ultrafiltration has been shown to reduce rehospitalizations in a randomized controlled trial of patients with decompensated HF. Future larger controlled clinical trials should evaluate the effect of ultrafiltration on survival... - Characteristics of "Stage D" heart failure: insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM)Maria R Costanzo
Midwest Heart Foundation, Naperville, IL, USA
Am Heart J 155:339-47. 2008..An improved understanding of the characteristics, treatment, and outcome of patients with "Stage D" heart failure (HF) may improve patient outcomes. We conducted an analysis of the ADHERE LM to enhance this understanding... - Predictors of quality of life at 1 month after implantation of a left ventricular assist deviceKathleen L Grady
Rush-Presbyterian-St Luke's Medical Center, Chicago, Ill, USA
Am J Crit Care 11:345-52. 2002..Psychological factors were the strongest predictors of satisfaction with overall quality of life... - Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)Kirkwood F Adams
Division of Cardiology, University of North Carolina, Chapel Hill, NC, USA
Am Heart J 149:209-16. 2005..Most available data on these patients are limited by patient selection criteria and study design of clinical trials and single-center studies... - An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National RegistryGregg C Fonarow
Ahmanson University of California Los Angeles Cardiomyopathy Center, University of California Los Angeles Medical Center, Los Angeles, CA 90095, USA
Am Heart J 153:74-81. 2007..The aim of this study was to determine whether BMI influences the mortality risk in acute decompensated HF, a subject not previously studied... - In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)William T Abraham
Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio, USA
J Am Coll Cardiol 46:57-64. 2005..We sought to compare the in-hospital mortality of patients with acute decompensated heart failure (ADHF) who were receiving parenteral treatment with one of four intravenous vasoactive medications... - Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure)Lynne Warner Stevenson
Brigham and Women s Hospital, 75 Francis St, Boston, Mass 02115, USA
Circulation 110:975-81. 2004..This study analyzes, on a post hoc basis, outcomes in patients undergoing inotropic infusions at randomization... - Influence of race in heart failure and cardiac transplantation: mortality differences are eliminated by specialized, comprehensive careSalpy V Pamboukian
Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois 60612, USA
J Card Fail 9:80-6. 2003.... - Importance of shape and surgically reshaping the left ventricle in ischemic cardiomyopathyJohn Strobeck
The Valley Hospital, Ridgewood, NJ, USA
Congest Heart Fail 10:45-53. 2004 - Longitudinal change in quality of life and impact on survival after left ventricular assist device implantationKathleen L Grady
Section of Cardiology, Rush Heart Failure and Cardiac Transplant Program, Rush University Medical Center, Chicago, Illinois 60612 3824, USA
Ann Thorac Surg 77:1321-7. 2004.... - Characteristics of patients hospitalized with acute decompensated heart failure who are referred for hospice carePaul J Hauptman
Division of Cardiology, Saint Louis University Hospital, 3635 Vista Avenue, St Louis, MO 63110, USA
Arch Intern Med 167:1990-7. 2007..However, little is known about hospice referral practices when patients are admitted because of acute decompensated heart failure... - Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006Edoardo Gronda
International Society for Heart and Lung Transplantation, Addison, Texas 75001, USA
J Heart Lung Transplant 25:1043-56. 2006 - High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE databaseJ Thomas Heywood
Scripps Clinic, La Jolla, California 92037, USA
J Card Fail 13:422-30. 2007..The prevalence of renal dysfunction in patients hospitalized with acute decompensated heart failure remains poorly characterized...